{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"An event is defined as relapse or transplant-related mortality.","groups":[{"description":"Tacro-MTX/Sirolimus GVHD Prophylaxis","id":"OG000","title":"Experiemental"},{"description":"Tacro-MTX GVHD Prophylaxis","id":"OG001","title":"Control"}],"populationDescription":"We made a large number of xenograft models but were not able to correlate resistance to rapamycin in mice with outcome on the trial with the numbers that we had. For this reason, no specific publications addressing this aim were put forward.","reportingStatus":"POSTED","timeFrame":"Up to 1 year","title":"Relative Contribution of Resistance by Acute Lymphoblastic Leukemia (ALL) Blasts to Cytolytic Therapy (e.g., Chemotherapy/Irradiation) as a Cause of Relapse Post-transplantation","type":"SECONDARY"}